A window-of-opportunity clinical trial of dasatinib in women with newly diagnosed endometrial cancer

被引：0
|
作者：
Linda R. Duska
Gina R. Petroni
Heather Lothamer
William Faust
Jan H. Beumer
Susan M. Christner
Anne M. Mills
Paula M. Fracasso
Sarah J. Parsons
机构：
[1] University of Virginia School of Medicine,Department of Obstetrics and Gynecology, Division of Gynecology Oncology
[2] University of Virginia School of Medicine,Department of Microbiology, Immunology, and Cancer Biology
[3] University of Virginia School of Medicine,Department of Public Health Services
[4] UPMC Hillman Cancer Center,Cancer Therapeutics Program
[5] University of Pittsburgh School of Medicine,Division of Hematology
[6] University of Pittsburgh,Oncology, Department of Medicine
[7] University of Virginia School of Medicine,Department of Pharmaceutical Sciences, School of Pharmacy
[8] University of Virginia School of Medicine,Department of Pathology
[9] University of Virginia Cancer Center,Department of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2019年 / 83卷
关键词：
Dasatinib; Endometrial cancer; Src inhibition; Pharmacodynamics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：473 / 482
页数：9
相关论文
共 50 条
  • [21] A pilot window-of-opportunity study of preoperative fluvastatin in localized prostate cancer
    Longo, Joseph
    Hamilton, Robert J.
    Masoomian, Mehdi
    Khurram, Najia
    Branchard, Emily
    Mullen, Peter J.
    Elbaz, Mohamad
    Hersey, Karen
    Chadwick, Dianne
    Ghai, Sangeet
    Andrews, David W.
    Chen, Eric X.
    van der Kwast, Theodorus H.
    Fleshner, Neil E.
    Penn, Linda Z.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23 (04) : 630 - 637
  • [22] High prevalence of metabolic syndrome in women newly diagnosed with endometrial cancer
    Kitson, Sarah J.
    Lindsay, Jennifer
    Sivalingam, Vanitha N.
    Rutter, Martin K.
    Crosbie, Emma J.
    GYNECOLOGIC ONCOLOGY REPORTS, 2018, 26 : 109 - 110
  • [23] Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages
    de Groot, John
    Penas-Prado, Marta
    Alfaro-Munoz, Kristin
    Hunter, Kathy
    Pei, Be Lian
    O'Brien, Barbara
    Weathers, Shiao-Pei
    Loghin, Monica
    Kamiya Matsouka, Carlos
    Yung, W. K. Alfred
    Mandel, Jacob
    Wu, Jimin
    Yuan, Ying
    Zhou, Shouhao
    Fuller, Gregory N.
    Huse, Jason
    Rao, Ganesh
    Weinberg, Jeffrey S.
    Prabhu, Sujit S.
    McCutcheon, Ian E.
    Lang, Frederick F.
    Ferguson, Sherise D.
    Sawaya, Raymond
    Colen, Rivka
    Yadav, Shalini S.
    Blando, Jorge
    Vence, Luis
    Allison, James
    Sharma, Padmanee
    Heimberger, Amy B.
    NEURO-ONCOLOGY, 2020, 22 (04) : 539 - 549
  • [24] Window of opportunity clinical trial designs to study cancer metabolism
    Francesca Aroldi
    Simon R. Lord
    British Journal of Cancer, 2020, 122 : 45 - 51
  • [25] Window of opportunity clinical trial designs to study cancer metabolism
    Aroldi, Francesca
    Lord, Simon R.
    BRITISH JOURNAL OF CANCER, 2020, 122 (01) : 45 - 51
  • [26] Window-of-opportunity trial of metastatic pancreatic cancer reveals potential mechanisms of response to targeting RAS/MEK signaling
    Tsuda, Motoyuki
    Daniel, Colin
    Wang, Xiaoyan
    Peltz, Carl
    Zimmny, Hayley
    Smith, Alexander
    Muschler, John
    Li, Xi
    Ozmen, Tugba Yildiran
    Ozmen, Furkan
    Keith, Dove
    Chin, Christopher Corless Koei
    Brody, Jonathan
    Lopez, Charles
    Mills, Gordon
    Sears, Rosalie
    CANCER RESEARCH, 2024, 84 (17)
  • [27] A window-of-opportunity trial of vorinostat (V) in patients with resectable non-small cell lung cancer (NSCLC)
    Dragnev, K. H.
    Ma, T.
    Galimberti, F.
    Erkmen, C. P.
    Memoli, V.
    Nugent, W.
    Rigas, J. R.
    Johnstone, D.
    Frandsen, A.
    Simeone, S.
    Czum, J.
    Li, H.
    DiRenzo, J.
    Freemantle, S.
    Dmitrovsky, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [28] Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial
    Sirwan Hadad
    Takayuki Iwamoto
    Lee Jordan
    Colin Purdie
    Susan Bray
    Lee Baker
    Gera Jellema
    Steve Deharo
    D. Grahame Hardie
    Lajos Pusztai
    Stacy Moulder-Thompson
    John A. Dewar
    Alastair M. Thompson
    Breast Cancer Research and Treatment, 2011, 128 : 783 - 794
  • [29] Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial
    Hadad, Sirwan
    Iwamoto, Takayuki
    Jordan, Lee
    Purdie, Colin
    Bray, Susan
    Baker, Lee
    Jellema, Gera
    Deharo, Steve
    Hardie, D. Grahame
    Pusztai, Lajos
    Moulder-Thompson, Stacy
    Dewar, John A.
    Thompson, Alastair M.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 128 (03) : 783 - 794
  • [30] The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression: a window-of-opportunity breast cancer trial
    Feldt, Maria
    Menard, Julien
    Rosendahl, Ann H.
    Lettiero, Barbara
    Bendahl, Par-Ola
    Belting, Mattias
    Borgquist, Signe
    CANCER & METABOLISM, 2020, 8 (01)
12345